Statistical Considerations of Food Allergy Prevention Studies

被引:10
作者
Bahnson, Henry T. [1 ]
du Toit, George [2 ,3 ]
Lack, Gideon [2 ,3 ]
机构
[1] Benaroya Res Inst, Immune Tolerance Network, Seattle, WA USA
[2] Kings Coll London, Div Asthma Allergy & Lung Biol, Dept Pediat Allergy, London, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
基金
美国国家卫生研究院;
关键词
Prevention studies; Food allergy; Statistical considerations; Complier average causal effect; LEAP; EAT; Dilution effects; Dropout; Imputation; Missing data; Tipping point analysis; Type I error; Type II error; PRINCIPAL STRATIFICATION; CLINICAL-TRIALS; PEANUT ALLERGY; TESTS; POWER; NONCOMPLIANCE; INFANTS; RISK;
D O I
10.1016/j.jaip.2016.12.007
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Clinical studies to prevent the development of food allergy have recently helped reshape public policy recommendations on the early introduction of allergenic foods. These trials are also prompting new research, and it is therefore important to address the unique design and analysis challenges of prevention trials. We highlight statistical concepts and give recommendations that clinical researchers may wish to adopt when designing future study protocols and analysis plans for prevention studies. Topics include selecting a study sample, addressing internal and external validity, improving statistical power, choosing alpha and beta, analysis innovations to address dilution effects, and analysis methods to deal with poor compliance, dropout, and missing data. (C) 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
引用
收藏
页码:274 / 282
页数:9
相关论文
共 30 条
  • [21] Non-inferiority trials:: the 'at least as good as' criterion with dichotomous data
    Laster, LL
    Johnson, MF
    Kotler, ML
    [J]. STATISTICS IN MEDICINE, 2006, 25 (07) : 1115 - 1130
  • [22] LILFORD RJ, 1990, NEW ENGL J MED, V322, P780
  • [23] Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trial
    Liublinska, Victoria
    Rubin, Donald B.
    [J]. STATISTICS IN MEDICINE, 2014, 33 (24) : 4170 - 4185
  • [24] Principal Stratification: A Tool for Understanding Variation in Program Effects Across Endogenous Subgroups
    Page, Lindsay C.
    Feller, Avi
    Grindal, Todd
    Miratrix, Luke
    Somers, Marie-Andree
    [J]. AMERICAN JOURNAL OF EVALUATION, 2015, 36 (04) : 514 - 531
  • [25] Palmer DJ, 2016, J ALLERGY CLIN IMMUN
  • [26] Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants
    Perkin, Michael R.
    Logan, Kirsty
    Tseng, Anna
    Raji, Bunmi
    Ayis, Salma
    Peacock, Janet
    Brough, Helen
    Marrs, Tom
    Radulovic, Suzana
    Craven, Joanna
    Flohr, Carsten
    Lack, Gideon
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (18) : 1733 - 1743
  • [27] A note on stratification in clinical trials
    Permutt, Thomas
    [J]. DRUG INFORMATION JOURNAL, 2007, 41 (06): : 719 - 722
  • [28] ON THE ROLE, DESIGN, AND ANALYSIS OF DISEASE PREVENTION TRIALS
    PRENTICE, RL
    [J]. CONTROLLED CLINICAL TRIALS, 1995, 16 (04): : 249 - 258
  • [29] A global survey of changing patterns of food allergy burden in children
    Prescott, Susan L.
    Pawankar, Ruby
    Allen, Katrina J.
    Campbell, Dianne E.
    Sinn, John K. H.
    Fiocchi, Alessandro
    Ebisawa, Motohiro
    Sampson, Hugh A.
    Beyer, Kirsten
    Lee, Bee-Wah
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2013, 6
  • [30] Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study
    Ye, Chenglin
    Beyene, Joseph
    Browne, Gina
    Thabane, Lehana
    [J]. BMJ OPEN, 2014, 4 (06):